{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:39:44Z","timestamp":1787319584759,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jaip.2022.12.039","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T13:14:22Z","timestamp":1673615662000},"page":"1401-1416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous Disease"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-5131","authenticated-orcid":false,"given":"Alexander H.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigit","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa S.","family":"Zerbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk See","family":"De Ravin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Blakely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Quezado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz E.","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Marko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Gallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.12.039_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2546190","article-title":"Variable presentation of the CYBB mutation in one family, approach to management, and a review of the literature","author":"Gavrilova","year":"2020","journal-title":"Case Rep Med"},{"key":"10.1016\/j.jaip.2022.12.039_bib2","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.12.039_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","article-title":"Genetic, biochemical, and clinical features of chronic granulomatous disease","volume":"79","author":"Segal","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2022.12.039_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","article-title":"Chronic granulomatous disease","volume":"27","author":"Holland","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaip.2022.12.039_bib5","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.039_bib6","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/hep.32539","article-title":"Tip of the iceberg: a comprehensive review of liver disease in inborn errors of immunity","volume":"76","author":"Sharma","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jaip.2022.12.039_bib7","author":"Song"},{"key":"10.1016\/j.jaip.2022.12.039_bib8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/bloodadvances.2022007652","article-title":"NADPH oxidase 2 limits amplification of IL-1\u03b2-G-CSF axis and an immature neutrophil subset in murine lung inflammation","volume":"7","author":"Song","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2022.12.039_bib9","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood.2021015365","article-title":"Macrophage NOX2 NADPH oxidase maintains alveolar homeostasis in mice","volume":"139","author":"Bhattacharya","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.12.039_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM197302222880802","article-title":"Gastrointestinal manifestations of chronic granulomatous disease","volume":"288","author":"Ament","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.12.039_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cgh.2015.10.030","article-title":"Gastrointestinal features of chronic granulomatous disease found during endoscopy","volume":"14","author":"Khangura","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.12.039_bib12","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/PAS.0b013e318297427d","article-title":"Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients","volume":"37","author":"Alimchandani","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2022.12.039_bib13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s10620-021-06978-4","article-title":"Gastrointestinal computed tomography findings in chronic granulomatous disease with subgroup clinicopathologic analysis","volume":"67","author":"Bhattacharya","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2022.12.039_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0022-3476(87)80452-3","article-title":"Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease","volume":"111","author":"Chin","year":"1987","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2022.12.039_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF02011110","article-title":"Esophageal involvement in chronic granulomatous disease\u2014case report and review","volume":"25","author":"Hiller","year":"1995","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jaip.2022.12.039_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0720-048X(97)00049-1","article-title":"Oesophageal narrowing in chronic granulomatous disease","volume":"27","author":"Ruiz-Contreras","year":"1998","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jaip.2022.12.039_bib17","first-page":"235","article-title":"Effect of corticosteroid therapy in esophageal stricture of a child with chronic granulomatous disease","volume":"7","author":"Abdolvahab","year":"2008","journal-title":"Iranian J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib18","first-page":"145","article-title":"Progressive esophageal dysfunction in chronic granulomatous disease","volume":"1","author":"Markowitz","year":"1982","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2022.12.039_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004836-200110000-00016","article-title":"Esophageal dysmotility in an adult with chronic granulomatous disease","volume":"33","author":"Golioto","year":"2001","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jaip.2022.12.039_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiology.178.1.1984302","article-title":"Esophageal inflammation and stricture: complication of chronic granulomatous disease of childhood","volume":"178","author":"Renner","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2022.12.039_bib21","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/ajg.2009.274","article-title":"Twenty-year follow-up of esophageal involvement in chronic granulomatous disease","volume":"104","author":"Laskey","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.12.039_bib22","first-page":"456","article-title":"Gastric antral narrowing in chronic granulomatous disease of childhood","volume":"54","author":"Griscom","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2022.12.039_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01625815","article-title":"Upper gastrointestinal and ultrasound examinations of gastric antral involvement in chronic granulomatous disease","volume":"14","author":"Kopen","year":"1984","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jaip.2022.12.039_bib24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1067\/mai.2003.1349","article-title":"The marble test for gastric outlet obstruction in chronic granulomatous disease","volume":"111","author":"Simons","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib25","first-page":"567","article-title":"Gastric outlet obstruction in chronic granulomatous disease of childhood","volume":"140","author":"Dickerman","year":"1986","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaip.2022.12.039_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease: report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2022.12.039_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.114.2.462","article-title":"Gastrointestinal involvement in chronic granulomatous disease","volume":"114","author":"Marciano","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2022.12.039_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ajg.2008.72","article-title":"Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn\u2019s disease","volume":"104","author":"Marks","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.12.039_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/000992289803700403","article-title":"Gastrointestinal complications of chronic granulomatous disease: case report and literature review","volume":"37","author":"Barton","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jaip.2022.12.039_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2007.06880.x","article-title":"Modern management of chronic granulomatous disease","volume":"140","author":"Seger","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2022.12.039_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MOH.0b013e32834115e7","article-title":"Advances in the diagnosis and treatment of chronic granulomatous disease","volume":"18","author":"Seger","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaip.2022.12.039_bib33","doi-asserted-by":"crossref","first-page":"rjz190","DOI":"10.1093\/jscr\/rjz190","article-title":"Spontaneous transmural perforation in eosinophilic esophagitis: RARE case presentation and role of esophageal stenting","volume":"2019","author":"Issa","year":"2019","journal-title":"J\u00a0Surg Case Rep"},{"key":"10.1016\/j.jaip.2022.12.039_bib34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1099\/jmm.0.46722-0","article-title":"Intractable colitis associated with chronic granulomatous disease","volume":"55","author":"Arimura","year":"2006","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.jaip.2022.12.039_bib35","doi-asserted-by":"crossref","first-page":"S1145","DOI":"10.1016\/S0016-5085(19)39830-0","article-title":"Determining predictors of gastrointestinal disease in patients with chronic granulomatous disease","volume":"156","author":"Kamal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.12.039_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.immuni.2013.11.020","article-title":"Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation","volume":"40","author":"Campbell","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2022.12.039_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2249.2011.04449.x","article-title":"Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease","volume":"166","author":"Horv\u00e1th","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2008.07.050","article-title":"Chronic granulomatous disease as a risk factor for autoimmune disease","volume":"122","author":"De Ravin","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib39","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jaip.2021.12.035","article-title":"Chronic granulomatous disease with inflammatory bowel disease: clinical presentation, treatment, and outcomes from the USIDNET Registry","volume":"10","author":"LaBere","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.039_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ibd.20912","article-title":"Chronic granulomatous disease","volume":"16","author":"Von Rosenvinge","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaip.2022.12.039_bib41","doi-asserted-by":"crossref","first-page":"AB623","DOI":"10.1016\/j.gie.2020.03.3741","article-title":"Small bowel endosocpy in chronic granulomatous disease-associated inflammatory bowel disease","volume":"91","author":"Bhattacharya","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaip.2022.12.039_bib42","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1053\/j.gastro.2019.11.102","article-title":"Small bowel involvement in chronic granulomatous disease colitis","volume":"158","author":"Bhattacharya","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.12.039_bib43","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/ajg.2009.181","article-title":"Gastrointestinal fistulae in chronic granulomatous disease","volume":"104","author":"Gopal","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.12.039_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10875-011-9608-5","article-title":"Utility of screening for chronic granulomatous disease in patients with inflammatory bowel disease","volume":"32","author":"Jaggi","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAP.0000000000000327","article-title":"A\u00a0pattern-based pathology approach to very early-onset inflammatory bowel disease: thinking beyond Crohn disease and ulcerative colitis","volume":"29","author":"Wilkins","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jaip.2022.12.039_bib46","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMra1907607","article-title":"Newer biologic and small-molecule therapies for inflammatory bowel disease","volume":"385","author":"Baumgart","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.12.039_bib47","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10875-007-9160-5","article-title":"Inflammatory manifestations in chronic granulomatous disease (CGD)","volume":"28","author":"Rosenzweig","year":"2008","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00063030-200216020-00005","article-title":"Infliximab: an updated review of its use in Crohn\u2019s disease and rheumatoid arthritis","volume":"16","author":"Keating","year":"2002","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaip.2022.12.039_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrgastro.2009.220","article-title":"The potential for disease modification in Crohn\u2019s disease","volume":"7","author":"Van Assche","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.12.039_bib50","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/657308","article-title":"Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease-related colitis","volume":"51","author":"Uzel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.039_bib51","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1073\/pnas.1322831111","article-title":"IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans","volume":"111","author":"De Luca","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2022.12.039_bib52","first-page":"95","article-title":"Anakinra for the inflammatory complications of chronic granulomatous disease","volume":"69","author":"van de Veerdonk","year":"2011","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaip.2022.12.039_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-020-00901-8","article-title":"Infections in patients with chronic granulomatous disease treated with tumor necrosis factor alpha blockers for inflammatory complications","volume":"41","author":"Conrad","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib54","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/ajg.2015.135","article-title":"Treatment with anakinra, a recombinant IL-1 receptor antagonist, unlikely to induce lasting remission in patients with CGD colitis","volume":"110","author":"Hahn","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2022.12.039_bib55","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A\u00a0simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaip.2022.12.039_bib56","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jaip.2017.07.035","article-title":"Treatment of chronic granulomatous disease\u2013associated fistulising colitis with vedolizumab","volume":"5","author":"Campbell","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.039_bib57","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/gastro\/goaa005","article-title":"The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease","volume":"8","author":"Kamal","year":"2020","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.jaip.2022.12.039_bib58","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cgh.2018.06.026","article-title":"Loss of response to vedolizumab and ability of dose intensification to restore response in patients with Crohn\u2019s disease or ulcerative colitis: a systematic review and meta-analysis","volume":"17","author":"Peyrin-Biroulet","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.12.039_bib59","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cgh.2021.02.025","article-title":"Five-year efficacy and safety of ustekinumab treatment in Crohn\u2019s disease: the IM-UNITI trial","volume":"20","author":"Sandborn","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.12.039_bib60","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/apt.16119","article-title":"Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy","volume":"52","author":"Panaccione","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2022.12.039_bib61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10875-016-0318-x","article-title":"Treatment of CGD-associated colitis with the IL-23 blocker ustekinumab","volume":"36","author":"Butte","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib62","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cgh.2021.03.039","article-title":"Safety and efficacy of ustekinumab in the inflammatory bowel disease of chronic granulomatous disease","volume":"20","author":"Bhattacharya","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.12.039_bib63","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.14309\/crj.2017.46","article-title":"Chronic granulomatous disease mimicking colonic crohn\u2019s disease successfully treated with infliximab","volume":"4","author":"Peixoto","year":"2017","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jaip.2022.12.039_bib64","doi-asserted-by":"crossref","first-page":"S-1090","DOI":"10.1016\/S0016-5085(22)62617-9","article-title":"Anal strictures in chronic granulomatous disease associated colitis: to dilate or not to dilate","volume":"162","author":"Yang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.12.039_bib65","first-page":"e170","article-title":"The role of surgery in the management of patients with refractory chronic granulomatous disease colitis","volume":"55","author":"Alvarez-Downing","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaip.2022.12.039_bib66","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaip.2020.12.014","article-title":"Exclusive enteral nutrition induced sustained changes in the microbiota and\u00a0improved inflammatory bowel disease in a pediatric patient with chronic\u00a0granulomatous disease","volume":"9","author":"Falcone","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.12.039_bib67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.21524","article-title":"Hepatic abnormalities in patients with chronic granulomatous disease","volume":"45","author":"Hussain","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jaip.2022.12.039_bib68","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1053\/j.gastro.2008.02.081","article-title":"Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease","volume":"134","author":"Feld","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.12.039_bib69","first-page":"S52","article-title":"Corticosteroid therapy in refractory liver abscesses in chronic granulomatous disease","volume":"31","author":"Leiding","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000658-200203000-00010","article-title":"Hepatic abscess in patients with chronic granulomatous disease","volume":"235","author":"Lublin","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaip.2022.12.039_bib71","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/368388","article-title":"Reinfection, rather than persistent infection, in patients with chronic granulomatous disease","volume":"187","author":"Guide","year":"2003","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.039_bib72","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2214\/AJR.05.1386","article-title":"CT and MRI of hepatic abscess in patients with chronic granulomatous disease","volume":"187","author":"Garcia-Eulate","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaip.2022.12.039_bib73","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/01.mph.0000139455.29962.be","article-title":"X-linked chronic granulomatous disease: first report of mutations in patients of Argentina","volume":"26","author":"Barese","year":"2004","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2022.12.039_bib74","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/107999099313541","article-title":"Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease","volume":"19","author":"Conte","year":"1999","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jaip.2022.12.039_bib75","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/adc.69.4.443","article-title":"Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease","volume":"69","author":"Hague","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2022.12.039_bib76","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/clinids\/19.4.770","article-title":"Treatment with intralesional granulocyte instillations and interferon-gamma for a patient with chronic granulomatous disease and multiple hepatic abscesses","volume":"19","author":"Lekstrom-Himes","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.039_bib77","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1086\/313626","article-title":"Treatment of hepatic abscesses in chronic granulomatous disease with granulocyte-macrophage colony-stimulating factor","volume":"30","author":"Martino","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.039_bib78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1774-9987.2005.00227.x","article-title":"Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis","volume":"9","author":"Ikincio\u01e7ullari","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaip.2022.12.039_bib79","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience","volume":"140","author":"Marciano","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib80","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.1537-2995.1996.36111297091747.x","article-title":"Alloimmunization after granulocyte transfusions","volume":"36","author":"Stroncek","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.jaip.2022.12.039_bib81","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1182\/bloodadvances.2020003224","article-title":"NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease","volume":"4","author":"de Ravin","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2022.12.039_bib82","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/jpsu.2003.50189","article-title":"Cut it out: managing hepatic abscesses in patients with chronic granulomatous disease","volume":"38","author":"Chen","year":"2003","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jaip.2022.12.039_bib83","article-title":"Corticosteroid therapy for liver abscesses in a neonate with chronic granulomatous disease","volume":"72","author":"Darabi","year":"2021","journal-title":"J Pediatr Surg Case Rep"},{"key":"10.1016\/j.jaip.2022.12.039_bib84","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.epsc.2018.06.001","article-title":"Successful treatment of liver abscesses with corticosteroids and antibiotics in an infant with chronic granulomatous disease","volume":"35","author":"Tam","year":"2018","journal-title":"J\u00a0Pediatr Surg Case Rep"},{"key":"10.1016\/j.jaip.2022.12.039_bib85","first-page":"S302","article-title":"Concomitant use of corticosteroid with antimicrobials for liver abscesses in patients with chronic granulomatous disease","volume":"34","author":"Oh","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.epsc.2014.05.003","article-title":"Successful management of liver abscesses in a patient with chronic granulomatous disease (CGD) using corticosteroids","volume":"2","author":"Tewari","year":"2014","journal-title":"J\u00a0Pediatr Surg Case Rep"},{"key":"10.1016\/j.jaip.2022.12.039_bib87","first-page":"279","article-title":"High dose steroid therapy for liver abscess in patients with chronic granulomatous disease (CGD)","volume":"36","author":"Gernez","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib88","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cix1012","article-title":"The changing paradigm of management of liver abscesses in chronic granulomatous disease","volume":"66","author":"Straughan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.12.039_bib89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.21258","article-title":"Nodular regenerative hyperplasia: not all nodules are created equal","volume":"44","author":"Reshamwala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaip.2022.12.039_bib90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000078479","article-title":"Nodular lesions associated with abnormal liver circulation","volume":"47","author":"Kondo","year":"2004","journal-title":"Intervirology"},{"key":"10.1016\/j.jaip.2022.12.039_bib91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.510260214","article-title":"Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver","volume":"26","author":"Shimamatsu","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaip.2022.12.039_bib92","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ecco-jcc\/jjv186","article-title":"Diagnostic and treatment options for severe IBD in female X-CGD carriers with non-random X-inactivation","volume":"10","author":"Hauck","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.jaip.2022.12.039_bib93","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/01.TP.0000163466.73485.5E","article-title":"Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients","volume":"79","author":"G\u00fcng\u00f6r","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jaip.2022.12.039_bib94","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","article-title":"Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000","volume":"100","author":"Seger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.12.039_bib95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.2009.07614.x","article-title":"Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth","volume":"145","author":"Soncini","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2022.12.039_bib96","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10875-019-00659-8","article-title":"on behalf of the Primary Immune Deficiency Treatment Consortium. Chronic granulomatous disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT","volume":"39","author":"Marsh","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib97","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10875-020-00852-0","article-title":"on behalf of the Primary Immune Deficiency Treatment Consortium. Correction: chronic granulomatous disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT","volume":"40","author":"Marsh","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.12.039_bib98","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/TP.0b013e31817c16eb","article-title":"Successful living-donor liver transplantation for chronic hepatic graft-versus-host disease after bone marrow transplantation for chronic granulomatous disease","volume":"86","author":"Yokoyama","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jaip.2022.12.039_bib99","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12185-011-0932-6","article-title":"Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection","volume":"94","author":"Kato","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaip.2022.12.039_bib100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:08Z","timestamp":1761975488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213219823000508"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.12.039","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}